Download Free Sample Report

In Vitro Diagnostics (IVD) Quality Control Product Market - Global Outlook and Forecast 2022-2028

In Vitro Diagnostics (IVD) Quality Control Product Market - Global Outlook and Forecast 2022-2028

  • Published on : 14 July 2022
  • Pages :102
  • Report Code:SMR-7205379

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

This report contains market size and forecasts of In Vitro Diagnostics (IVD) Quality Control Product in Global, including the following market information:
  • Global In Vitro Diagnostics (IVD) Quality Control Product Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global top five companies in 2021 (%)
The global In Vitro Diagnostics (IVD) Quality Control Product market was valued at 798.5 million in 2021 and is projected to reach US$ 911.8 million by 2028, at a CAGR of 1.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Quality Control Products Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of In Vitro Diagnostics (IVD) Quality Control Product include Bio-Rad Laboratories, Thermo Fisher Scientific, Randox Laboratories, Roche Diagnostics, Abbott Diagnostics, Helena Laboratories, Seracare Life Sciences, Technopath Clinical Diagnostics and Sun Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the In Vitro Diagnostics (IVD) Quality Control Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In Vitro Diagnostics (IVD) Quality Control Product Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global In Vitro Diagnostics (IVD) Quality Control Product Market Segment Percentages, by Type, 2021 (%)
  • Quality Control Products
  • Quality Assurance Services
  • Data Management Solutions
Global In Vitro Diagnostics (IVD) Quality Control Product Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global In Vitro Diagnostics (IVD) Quality Control Product Market Segment Percentages, by Application, 2021 (%)
  • Clinical Chemistry
  • Immunochemistry
  • Hematology
  • Molecular Diagnostics
  • Others
Global In Vitro Diagnostics (IVD) Quality Control Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global In Vitro Diagnostics (IVD) Quality Control Product Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
  • Key companies In Vitro Diagnostics (IVD) Quality Control Product revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies In Vitro Diagnostics (IVD) Quality Control Product revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Roche Diagnostics
  • Abbott Diagnostics
  • Helena Laboratories
  • Seracare Life Sciences
  • Technopath Clinical Diagnostics
  • Sun Diagnostics
  • Zeptometrix Corporation
  • ISOLAB
  • Sysmex Corporation
  • Fortress Diagnostics
  • Meril Life Sciences
  • Multiplicom
  • Future Diagnostics Solutions
  • Surmodics